MAGNA MINING INC (NICU.CA) Fundamental Analysis & Valuation

TSX-V:NICU • CA55925F1027

2.85 CAD
+0.1 (+3.64%)
Last: Mar 4, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This NICU.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to NICU. NICU was compared to 816 industry peers in the Metals & Mining industry. The financial health of NICU is average, but there are quite some concerns on its profitability. NICU is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. NICU.CA Profitability Analysis

1.1 Basic Checks

  • NICU had positive earnings in the past year.
  • In the past year NICU has reported a negative cash flow from operations.
  • NICU had negative earnings in each of the past 5 years.
  • In the past 5 years NICU always reported negative operating cash flow.
NICU.CA Yearly Net Income VS EBIT VS OCF VS FCFNICU.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M

1.2 Ratios

  • NICU has a better Return On Assets (6.35%) than 89.58% of its industry peers.
  • The Return On Equity of NICU (13.67%) is better than 91.54% of its industry peers.
Industry RankSector Rank
ROA 6.35%
ROE 13.67%
ROIC N/A
ROA(3y)-53.61%
ROA(5y)N/A
ROE(3y)-65.13%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NICU.CA Yearly ROA, ROE, ROICNICU.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400

1.3 Margins

  • With an excellent Profit Margin value of 45.30%, NICU belongs to the best of the industry, outperforming 98.04% of the companies in the same industry.
  • NICU does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 45.3%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NICU.CA Yearly Profit, Operating, Gross MarginsNICU.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. NICU.CA Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, NICU has more shares outstanding
  • The number of shares outstanding for NICU has been increased compared to 5 years ago.
  • Compared to 1 year ago, NICU has an improved debt to assets ratio.
NICU.CA Yearly Shares OutstandingNICU.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
NICU.CA Yearly Total Debt VS Total AssetsNICU.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

  • An Altman-Z score of 4.60 indicates that NICU is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 4.60, NICU is in line with its industry, outperforming 51.35% of the companies in the same industry.
  • NICU has a Debt/Equity ratio of 0.20. This is a healthy value indicating a solid balance between debt and equity.
  • NICU has a worse Debt to Equity ratio (0.20) than 66.05% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF N/A
Altman-Z 4.6
ROIC/WACCN/A
WACCN/A
NICU.CA Yearly LT Debt VS Equity VS FCFNICU.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

2.3 Liquidity

  • NICU has a Current Ratio of 2.43. This indicates that NICU is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 2.43, NICU is in line with its industry, outperforming 56.50% of the companies in the same industry.
  • NICU has a Quick Ratio of 2.07. This indicates that NICU is financially healthy and has no problem in meeting its short term obligations.
  • NICU has a Quick ratio of 2.07. This is comparable to the rest of the industry: NICU outperforms 54.04% of its industry peers.
Industry RankSector Rank
Current Ratio 2.43
Quick Ratio 2.07
NICU.CA Yearly Current Assets VS Current LiabilitesNICU.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. NICU.CA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 129.05% over the past year.
EPS 1Y (TTM)129.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-89.47%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • NICU is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 109.05% yearly.
  • Based on estimates for the next years, NICU will show a very strong growth in Revenue. The Revenue will grow by 166.02% on average per year.
EPS Next Y-145%
EPS Next 2Y53.3%
EPS Next 3Y223.48%
EPS Next 5Y109.05%
Revenue Next Year881.02%
Revenue Next 2Y360.82%
Revenue Next 3Y285.67%
Revenue Next 5Y166.02%

3.3 Evolution

NICU.CA Yearly Revenue VS EstimatesNICU.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 2025 2026 2027 2028 100M 200M 300M
NICU.CA Yearly EPS VS EstimatesNICU.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 0.2 0.4 0.6

More info and screens

Find the best growth stocksShow best growing peers

2

4. NICU.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 142.50, NICU can be considered very expensive at the moment.
  • 86.15% of the companies in the same industry are more expensive than NICU, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 27.03. NICU is valued rather expensively when compared to this.
  • Based on the Price/Forward Earnings ratio of 403.11, the valuation of NICU can be described as expensive.
  • Based on the Price/Forward Earnings ratio, NICU is valued cheaper than 86.15% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 25.11, NICU is valued quite expensively.
Industry RankSector Rank
PE 142.5
Fwd PE 403.11
NICU.CA Price Earnings VS Forward Price EarningsNICU.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300 400

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NICU.CA Per share dataNICU.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2 0.3

4.3 Compensation for Growth

  • NICU's earnings are expected to grow with 223.48% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y53.3%
EPS Next 3Y223.48%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. NICU.CA Dividend Analysis

5.1 Amount

  • No dividends for NICU!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

NICU.CA Fundamentals: All Metrics, Ratios and Statistics

MAGNA MINING INC

TSX-V:NICU (3/4/2026, 7:00:00 PM)

2.85

+0.1 (+3.64%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)11-25
Earnings (Next)04-07
Inst Owners14.19%
Inst Owner ChangeN/A
Ins Owners7.08%
Ins Owner ChangeN/A
Market Cap712.16M
Revenue(TTM)39.20M
Net Income(TTM)10.38M
Analysts82.5
Price Target4.83 (69.47%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)17.34%
PT rev (3m)19.56%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)27.41%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.83%
Revenue NY rev (3m)2.03%
Valuation
Industry RankSector Rank
PE 142.5
Fwd PE 403.11
P/S 31.07
P/FCF N/A
P/OCF N/A
P/B 9.38
P/tB 9.38
EV/EBITDA N/A
EPS(TTM)0.02
EY0.7%
EPS(NY)0.01
Fwd EY0.25%
FCF(TTM)-0.13
FCFYN/A
OCF(TTM)-0.1
OCFYN/A
SpS0.09
BVpS0.3
TBVpS0.3
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0.37
Profitability
Industry RankSector Rank
ROA 6.35%
ROE 13.67%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 45.3%
GM N/A
FCFM N/A
ROA(3y)-53.61%
ROA(5y)N/A
ROE(3y)-65.13%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 170.6%
Cap/Sales 30.94%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.43
Quick Ratio 2.07
Altman-Z 4.6
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)86.02%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)129.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-89.47%
EPS Next Y-145%
EPS Next 2Y53.3%
EPS Next 3Y223.48%
EPS Next 5Y109.05%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year881.02%
Revenue Next 2Y360.82%
Revenue Next 3Y285.67%
Revenue Next 5Y166.02%
EBIT growth 1Y-63.23%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-53.8%
EBIT Next 3Y80.9%
EBIT Next 5Y75.23%
FCF growth 1Y-47.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-15.53%
OCF growth 3YN/A
OCF growth 5YN/A

MAGNA MINING INC / NICU.CA FAQ

Can you provide the ChartMill fundamental rating for MAGNA MINING INC?

ChartMill assigns a fundamental rating of 3 / 10 to NICU.CA.


Can you provide the valuation status for MAGNA MINING INC?

ChartMill assigns a valuation rating of 2 / 10 to MAGNA MINING INC (NICU.CA). This can be considered as Overvalued.


Can you provide the profitability details for MAGNA MINING INC?

MAGNA MINING INC (NICU.CA) has a profitability rating of 3 / 10.


Can you provide the PE and PB ratios for NICU stock?

The Price/Earnings (PE) ratio for MAGNA MINING INC (NICU.CA) is 142.5 and the Price/Book (PB) ratio is 9.38.


What is the financial health of MAGNA MINING INC (NICU.CA) stock?

The financial health rating of MAGNA MINING INC (NICU.CA) is 4 / 10.